These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 11589933

  • 1. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study.
    Marcil I, Stern RS.
    Lancet; 2001 Sep 29; 358(9287):1042-5. PubMed ID: 11589933
    [Abstract] [Full Text] [Related]

  • 2. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
    Stern RS, PUVA Follow-Up Study.
    J Am Acad Dermatol; 2012 Apr 29; 66(4):553-62. PubMed ID: 22264671
    [Abstract] [Full Text] [Related]

  • 3. Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: response to long-term acitretin maintenance.
    van de Kerkhof PC, de Rooij MJ.
    Br J Dermatol; 1997 Feb 29; 136(2):275-8. PubMed ID: 9068750
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
    Stern RS, Laird N, Melski J, Parrish JA, Fitzpatrick TB, Bleich HL.
    N Engl J Med; 1984 May 03; 310(18):1156-61. PubMed ID: 6709010
    [Abstract] [Full Text] [Related]

  • 6. The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study.
    Nijsten TE, Stern RS.
    J Invest Dermatol; 2003 Aug 03; 121(2):252-8. PubMed ID: 12880415
    [Abstract] [Full Text] [Related]

  • 7. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
    Stern RS, Liebman EJ, Väkevä L.
    J Natl Cancer Inst; 1998 Sep 02; 90(17):1278-84. PubMed ID: 9731734
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The risk of melanoma in association with long-term exposure to PUVA.
    Stern RS, PUVA Follow up Study.
    J Am Acad Dermatol; 2001 May 02; 44(5):755-61. PubMed ID: 11312420
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study.
    Paul CF, Ho VC, McGeown C, Christophers E, Schmidtmann B, Guillaume JC, Lamarque V, Dubertret L.
    J Invest Dermatol; 2003 Feb 02; 120(2):211-6. PubMed ID: 12542524
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
    Katz KA, Marcil I, Stern RS.
    J Invest Dermatol; 2002 Jun 02; 118(6):1038-43. PubMed ID: 12060400
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Skin tumors in the European PUVA Study. Eight-year follow-up of 1,643 patients treated with PUVA for psoriasis.
    Henseler T, Christophers E, Hönigsmann H, Wolff K.
    J Am Acad Dermatol; 1987 Jan 02; 16(1 Pt 1):108-16. PubMed ID: 3805379
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Risks of cancer associated with long-term exposure to PUVA in humans: current status--1991.
    Stern RS.
    Blood Cells; 1992 Jan 02; 18(1):91-7; discussion 98-9. PubMed ID: 1617196
    [Abstract] [Full Text] [Related]

  • 18. Skin carcinomas and treatment with photochemotherapy (PUVA).
    Lindskov R.
    Acta Derm Venereol; 1983 Jan 02; 63(3):223-6. PubMed ID: 6192635
    [Abstract] [Full Text] [Related]

  • 19. Treatments for psoriasis and the risk of malignancy.
    Patel RV, Clark LN, Lebwohl M, Weinberg JM.
    J Am Acad Dermatol; 2009 Jun 02; 60(6):1001-17. PubMed ID: 19344980
    [Abstract] [Full Text] [Related]

  • 20. Cutaneous malignancies during treatment with efalizumab and infliximab: When temporal relationship does not mean causality.
    Di Lernia V, Ricci C.
    J Dermatolog Treat; 2011 Aug 02; 22(4):229-32. PubMed ID: 20666674
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.